Workflow
神奇制药(600613) - 2016 Q3 - 季度财报
ShenqiShenqi(SH:600613)2016-10-28 16:00

Financial Performance - Net profit attributable to shareholders decreased by 33.30% to CNY 98,033,181.80 for the period from January to September[6] - Operating revenue for the first nine months was CNY 983,116,935.41, a slight decrease of 0.14% compared to the same period last year[6] - Basic and diluted earnings per share both decreased by 35.71% to CNY 0.18[7] - The company reported a net profit of CNY 137,348.67 from non-operating income for the first nine months[10] - The company's net profit for the reporting period was 98,033,181.80 RMB, a decrease of 33.30% compared to the same period last year[15] - The company experienced a 30.61% decrease in other comprehensive income, which fell to 52,696,578.13 RMB, primarily due to the decline in the value of previously purchased stocks[15] - The total comprehensive income attributable to the parent company for the first nine months of 2016 was CNY 150,729,759.93, down from CNY 226,328,345.01 in the previous year, indicating a decline of about 33.4%[30] - The net profit attributable to the parent company for Q3 2016 was CNY 28,845,163.28, compared to CNY 52,705,542.77 in the same period last year, reflecting a decrease of approximately 45.4%[30] Cash Flow - Net cash flow from operating activities improved significantly, reaching CNY 91,189,900.54, a 773.39% increase compared to the same period last year[6] - Cash flow from operating activities for the first nine months of 2016 was CNY 1,136,733,382.64, compared to CNY 926,975,073.67 in the previous year, representing an increase of approximately 22.5%[35] - The net cash flow from operating activities for Q3 2016 was ¥91,189,900.54, a significant improvement compared to a net outflow of ¥13,542,008.93 in the same period last year[36] - Total cash inflow from operating activities amounted to ¥1,267,500,087.80, while cash outflow was ¥1,176,310,187.26, resulting in a net increase of approximately 7.8% in cash flow from operations year-over-year[36] - The cash flow from operating activities for the first nine months of 2016 showed a net outflow of -¥4,804,845.35, an improvement from -¥9,648,262.03 in the same period last year[39] Assets and Liabilities - Total assets increased by 3.72% to CNY 2,770,169,086.90 compared to the end of the previous year[6] - The company's current assets totaled CNY 1,681,842,112.15, up from CNY 1,592,868,597.04 at the start of the year, indicating an increase of about 5.6%[22] - Total liabilities stood at CNY 454,000,119.85, compared to CNY 384,976,881.85 at the beginning of the year, showing an increase of around 17.9%[24] - The total amount of accounts payable increased by 47.05% to 151,711,503.83 RMB, driven by increased inventory reserves[14] - The company's total liabilities and equity amounted to CNY 2,770,169,086.90, consistent with the total assets, indicating a balanced financial position[24] Shareholder Information - The total number of shareholders reached 35,638 by the end of the reporting period[12] - The largest shareholder, Guizhou Magic Investment Co., Ltd., holds 24.59% of the shares, with 126,600,000 shares pledged[12] Operating Costs and Revenue - Operating costs increased by 46.10% year-on-year, amounting to 332,718,401.83 RMB, primarily due to a rise in pharmaceutical business costs[15] - Total revenue for Q3 2016 was CNY 337,293,822.86, a decrease of 3.6% compared to CNY 350,211,477.61 in Q3 2015[28] - Total operating costs for Q3 2016 were CNY 302,711,481.80, an increase of 4.5% from CNY 288,945,328.04 in Q3 2015[29] Investment Income - The company reported a significant increase in other receivables, which rose to CNY 352,206,012.19 from CNY 104,204,614.55, a growth of approximately 238.5%[22] - The company reported an investment income of CNY 130,713,780.18 for the first nine months of 2016, indicating a strong performance in this area[32] - The company reported investment income of CNY 1,541,827.95 for Q3 2016, compared to no investment income reported in Q3 2015[29] - The company reported a 50.56% decline in investment income, totaling 1,953,994.47 RMB, due to reduced external investments and lack of profit distribution from some projects[15] Future Outlook - The company aims to enhance its market expansion strategies and product development in the upcoming quarters, focusing on innovation and operational efficiency[30]